Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged Oral Tranexamic Acid in Primary Total Knee Arthroplasty
NCT06894719Phase 4Not yet recruiting
- Sponsor
- Rush University Medical Center
- Start
- Dec 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in total knee arthroplasty (TKA) (3 arms), sponsored by Rush University Medical Center. Primary endpoint: Knee Range of Motion at 6 weeks. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
total knee arthroplasty (TKA)
Beyond the preview
Go deeper on NCT06894719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06894719.